JP2018138054A - Rna依存性標的dna修飾およびrna依存性転写調節のための方法および組成物
- Google Patents
Rna依存性標的dna修飾およびrna依存性転写調節のための方法および組成物
Download PDF
Info
Publication number
JP2018138054A
JP2018138054A
JP2018097369A
JP2018097369A
JP2018138054A
JP 2018138054 A
JP2018138054 A
JP 2018138054A
JP 2018097369 A
JP2018097369 A
JP 2018097369A
JP 2018097369 A
JP2018097369 A
JP 2018097369A
JP 2018138054 A
JP2018138054 A
JP 2018138054A
Authority
JP
Japan
Prior art keywords
activity
dna
site
cells
rna
Prior art date
2012-05-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018097369A
Other languages
English (en )
Other versions
JP2018138054A5
(ja
JP6692856B2
(ja
Inventor
ジネク,マーテイン
Jinek Martin
チヤーペンテイエ,エマニユエル
Charpentier Emmanuelle
チリ
Chylinski Krzysztof
チリンスキー,クシシユトフ
Harrison Doudna Cate James
ドウドナ・ケイト,ジエイムズ・ハリソン
Wendell Lim
リム,ウエンデル
Lei Qi
キイ,レイ
A Doudna Jennifer
ドウドナ,ジエニフアー・エー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Wien
University of California
Original Assignee
Universitaet Wien
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2012-05-25
Filing date
2018-05-21
Publication date
2018-09-06
Family has litigation
First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=49624232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2018138054(A)
"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
2018-05-21
Application filed by Universitaet Wien, University of California
filed
Critical
Universitaet Wien
2018-09-06
Publication of JP2018138054A
publication
Critical
patent/JP2018138054A/ja
2018-11-15
Publication of JP2018138054A5
publication
Critical
patent/JP2018138054A5/ja
2020-05-13
Application granted
granted
Critical
2020-05-13
Publication of JP6692856B2
publication
Critical
patent/JP6692856B2/ja
Status
Active
legal-status
Critical
Current
2033-03-15
Anticipated expiration
legal-status
Critical
Links
238000000034
method
Methods
0.000
title
claims
description
157
230000035897
transcription
Effects
0.000
title
claims
description
88
238000013518
transcription
Methods
0.000
title
claims
description
88
239000000203
mixture
Substances
0.000
title
claims
description
33
230000008836
DNA modification
Effects
0.000
title
description
2
230000000694
effects
Effects
0.000
claims
abstract
description
433
108090000765
processed proteins & peptides
Proteins
0.000
claims
abstract
description
423
229920001184
polypeptide
Polymers
0.000
claims
abstract
description
417
102000004196
processed proteins & peptides
Human genes
0.000
claims
abstract
description
417
230000008685
targeting
Effects
0.000
claims
abstract
description
361
239000002773
nucleotide
Substances
0.000
claims
abstract
description
268
125000003729
nucleotide group
Chemical group
0.000
claims
abstract
description
267
230000000295
complement effect
Effects
0.000
claims
abstract
description
135
108090000623
proteins and genes
Proteins
0.000
claims
abstract
description
128
102000004169
proteins and genes
Human genes
0.000
claims
abstract
description
94
101710163270
Nuclease
Proteins
0.000
claims
abstract
description
51
230000000051
modifying effect
Effects
0.000
claims
abstract
description
8
108091032973
(ribonucleotides)n+m
Proteins
0.000
claims
description
425
210000004027
cell
Anatomy
0.000
claims
description
350
108020004414
DNA
Proteins
0.000
claims
description
218
108091033409
CRISPR
Proteins
0.000
claims
description
169
150000007523
nucleic acids
Chemical class
0.000
claims
description
163
102000040430
polynucleotide
Human genes
0.000
claims
description
138
108091033319
polynucleotide
Proteins
0.000
claims
description
138
239000002157
polynucleotide
Substances
0.000
claims
description
138
102000039446
nucleic acids
Human genes
0.000
claims
description
129
108020004707
nucleic acids
Proteins
0.000
claims
description
129
125000003275
alpha amino acid group
Chemical group
0.000
claims
description
117
230000027455
binding
Effects
0.000
claims
description
75
101150106478
GPS1 gene
Proteins
0.000
claims
description
69
108091028043
Nucleic acid sequence
Proteins
0.000
claims
description
67
239000013604
expression vector
Substances
0.000
claims
description
61
230000004570
RNA-binding
Effects
0.000
claims
description
60
102000004190
Enzymes
Human genes
0.000
claims
description
46
108090000790
Enzymes
Proteins
0.000
claims
description
46
230000002255
enzymatic effect
Effects
0.000
claims
description
45
230000001105
regulatory effect
Effects
0.000
claims
description
42
230000004048
modification
Effects
0.000
claims
description
39
238000012986
modification
Methods
0.000
claims
description
39
150000001413
amino acids
Chemical class
0.000
claims
description
37
238000003259
recombinant expression
Methods
0.000
claims
description
37
230000035772
mutation
Effects
0.000
claims
description
36
108060004795
Methyltransferase
Proteins
0.000
claims
description
31
238000003776
cleavage reaction
Methods
0.000
claims
description
30
230000007017
scission
Effects
0.000
claims
description
30
210000000130
stem cell
Anatomy
0.000
claims
description
29
230000001580
bacterial effect
Effects
0.000
claims
description
25
230000005782
double-strand break
Effects
0.000
claims
description
25
230000014509
gene expression
Effects
0.000
claims
description
25
102000016397
Methyltransferase
Human genes
0.000
claims
description
23
210000003527
eukaryotic cell
Anatomy
0.000
claims
description
23
241000282414
Homo sapiens
Species
0.000
claims
description
22
101000615488
Homo sapiens Methyl-CpG-binding domain protein 2
Proteins
0.000
claims
description
22
102100021299
Methyl-CpG-binding domain protein 2
Human genes
0.000
claims
description
22
239000003153
chemical reaction reagent
Substances
0.000
claims
description
22
102000040650
(ribonucleotides)n+m
Human genes
0.000
claims
description
21
238000000338
in vitro
Methods
0.000
claims
description
21
108091000080
Phosphotransferase
Proteins
0.000
claims
description
20
230000001939
inductive effect
Effects
0.000
claims
description
20
102000020233
phosphotransferase
Human genes
0.000
claims
description
20
108010033040
Histones
Proteins
0.000
claims
description
19
230000001747
exhibiting effect
Effects
0.000
claims
description
19
230000002829
reductive effect
Effects
0.000
claims
description
19
102000005421
acetyltransferase
Human genes
0.000
claims
description
18
108020002494
acetyltransferase
Proteins
0.000
claims
description
18
210000004962
mammalian cell
Anatomy
0.000
claims
description
18
210000004602
germ cell
Anatomy
0.000
claims
description
17
210000001082
somatic cell
Anatomy
0.000
claims
description
17
230000006780
non-homologous end joining
Effects
0.000
claims
description
16
241000193996
Streptococcus pyogenes
Species
0.000
claims
description
15
230000015572
biosynthetic process
Effects
0.000
claims
description
15
241000251539
Vertebrata <Metazoa>
Species
0.000
claims
description
14
230000004913
activation
Effects
0.000
claims
description
14
102000004160
Phosphoric Monoester Hydrolases
Human genes
0.000
claims
description
13
108090000608
Phosphoric Monoester Hydrolases
Proteins
0.000
claims
description
13
241000283984
Rodentia
Species
0.000
claims
description
13
102000006275
Ubiquitin-Protein Ligases
Human genes
0.000
claims
description
13
108010083111
Ubiquitin-Protein Ligases
Proteins
0.000
claims
description
13
230000034431
double-strand break repair via homologous recombination
Effects
0.000
claims
description
13
210000005260
human cell
Anatomy
0.000
claims
description
13
238000001727
in vivo
Methods
0.000
claims
description
13
CZPWVGJYEJSRLH-UHFFFAOYSA-N
Pyrimidine
Chemical compound
C1=CN=CN=C1
CZPWVGJYEJSRLH-UHFFFAOYSA-N
0.000
claims
description
12
230000006154
adenylylation
Effects
0.000
claims
description
12
230000009504
deubiquitination
Effects
0.000
claims
description
12
241000251468
Actinopterygii
Species
0.000
claims
description
11
241000271566
Aves
Species
0.000
claims
description
11
241000196324
Embryophyta
Species
0.000
claims
description
11
241000700159
Rattus
Species
0.000
claims
description
11
239000000872
buffer
Substances
0.000
claims
description
11
230000002103
transcriptional effect
Effects
0.000
claims
description
11
230000033616
DNA repair
Effects
0.000
claims
description
10
210000004102
animal cell
Anatomy
0.000
claims
description
10
210000000349
chromosome
Anatomy
0.000
claims
description
10
238000010790
dilution
Methods
0.000
claims
description
10
239000012895
dilution
Substances
0.000
claims
description
10
230000007498
myristoylation
Effects
0.000
claims
description
10
230000005778
DNA damage
Effects
0.000
claims
description
9
231100000277
DNA damage
Toxicity
0.000
claims
description
9
102220605874
Cytosolic arginine sensor for mTORC1 subunit 2_D10A_mutation
Human genes
0.000
claims
description
8
102000003960
Ligases
Human genes
0.000
claims
description
8
108090000364
Ligases
Proteins
0.000
claims
description
8
108091093078
Pyrimidine dimer
Proteins
0.000
claims
description
8
102000018120
Recombinases
Human genes
0.000
claims
description
8
108010091086
Recombinases
Proteins
0.000
claims
description
8
102000008579
Transposases
Human genes
0.000
claims
description
8
108010020764
Transposases
Proteins
0.000
claims
description
8
230000029936
alkylation
Effects
0.000
claims
description
8
238000005804
alkylation reaction
Methods
0.000
claims
description
8
230000027832
depurination
Effects
0.000
claims
description
8
239000013635
pyrimidine dimer
Substances
0.000
claims
description
8
108010061833
Integrases
Proteins
0.000
claims
description
7
241000699666
Mus <mouse, genus>
Species
0.000
claims
description
7
230000009615
deamination
Effects
0.000
claims
description
7
238000006481
deamination reaction
Methods
0.000
claims
description
7
210000001236
prokaryotic cell
Anatomy
0.000
claims
description
7
230000009261
transgenic effect
Effects
0.000
claims
description
7
241000283707
Capra
Species
0.000
claims
description
6
230000010718
Oxidation Activity
Effects
0.000
claims
description
6
241001494479
Pecora
Species
0.000
claims
description
6
230000006114
demyristoylation
Effects
0.000
claims
description
6
230000001965
increasing effect
Effects
0.000
claims
description
6
230000000087
stabilizing effect
Effects
0.000
claims
description
6
241000894006
Bacteria
Species
0.000
claims
description
5
241000282412
Homo
Species
0.000
claims
description
5
241000699670
Mus sp.
Species
0.000
claims
description
5
238000004519
manufacturing process
Methods
0.000
claims
description
5
230000006798
recombination
Effects
0.000
claims
description
5
238000005215
recombination
Methods
0.000
claims
description
5
241000124008
Mammalia
Species
0.000
claims
description
4
108700019146
Transgenes
Proteins
0.000
claims
description
4
239000011534
wash buffer
Substances
0.000
claims
description
4
241000203069
Archaea
Species
0.000
claims
description
3
241000238631
Hexapoda
Species
0.000
claims
description
3
102000008157
Histone Demethylases
Human genes
0.000
claims
description
3
108010074870
Histone Demethylases
Proteins
0.000
claims
description
3
241001465754
Metazoa
Species
0.000
claims
description
3
239000012190
activator
Substances
0.000
claims
description
3
238000010367
cloning
Methods
0.000
claims
description
3
241000243321
Cnidaria
Species
0.000
claims
description
2
241000195493
Cryptophyta
Species
0.000
claims
description
2
241000255925
Diptera
Species
0.000
claims
description
2
KDXKERNSBIXSRK-UHFFFAOYSA-N
Lysine
Natural products
NCCCCC(N)C(O)=O
KDXKERNSBIXSRK-UHFFFAOYSA-N
0.000
claims
description
2
239000004472
Lysine
Substances
0.000
claims
description
2
230000001737
promoting effect
Effects
0.000
claims
description
2
238000006243
chemical reaction
Methods
0.000
claims
4
OSXFATOLZGZLSK-UHFFFAOYSA-N
6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine
Chemical compound
C=12C=C(OC)C(OC)=CC2=NC(N2CCN(C)CCC2)=NC=1NC(CC1)CCN1CC1=CC=CC=C1
OSXFATOLZGZLSK-UHFFFAOYSA-N
0.000
claims
2
108010016918
Histone-Lysine N-Methyltransferase
Proteins
0.000
claims
2
102000000581
Histone-lysine N-methyltransferase
Human genes
0.000
claims
2
102100034343
Integrase
Human genes
0.000
claims
2
102000007077
Lysine Acetyltransferases
Human genes
0.000
claims
2
108010033293
Lysine Acetyltransferases
Proteins
0.000
claims
2
238000003032
molecular docking
Methods
0.000
claims
2
241000269350
Anura
Species
0.000
claims
1
102100035102
E3 ubiquitin-protein ligase MYCBP2
Human genes
0.000
claims
1
230000030570
cellular localization
Effects
0.000
claims
1
230000001335
demethylating effect
Effects
0.000
claims
1
230000002093
peripheral effect
Effects
0.000
claims
1
230000007115
recruitment
Effects
0.000
claims
1
238000013461
design
Methods
0.000
abstract
description
10
238000005516
engineering process
Methods
0.000
abstract
description
3
230000004952
protein activity
Effects
0.000
abstract
description
2
235000018102
proteins
Nutrition
0.000
description
86
108091079001
CRISPR RNA
Proteins
0.000
description
49
230000000875
corresponding effect
Effects
0.000
description
38
235000001014
amino acid
Nutrition
0.000
description
32
229940024606
amino acid
Drugs
0.000
description
29
241000894007
species
Species
0.000
description
24
108091034117
Oligonucleotide
Proteins
0.000
description
20
230000001404
mediated effect
Effects
0.000
description
18
-1
Dnmt
3b
Proteins
0.000
description
17
201000010099
disease
Diseases
0.000
description
16
208000037265
diseases, disorders, signs and symptoms
Diseases
0.000
description
16
239000013598
vector
Substances
0.000
description
16
125000005647
linker group
Chemical group
0.000
description
15
235000000346
sugar
Nutrition
0.000
description
15
238000010354
CRISPR gene editing
Methods
0.000
description
14
150000001875
compounds
Chemical class
0.000
description
14
UYTPUPDQBNUYGX-UHFFFAOYSA-N
guanine
Chemical compound
O=C1NC(N)=NC2=C1N=CN2
UYTPUPDQBNUYGX-UHFFFAOYSA-N
0.000
description
14
238000009396
hybridization
Methods
0.000
description
14
239000013612
plasmid
Substances
0.000
description
14
102000053602
DNA
Human genes
0.000
description
13
108010043121
Green Fluorescent Proteins
Proteins
0.000
description
13
102000004144
Green Fluorescent Proteins
Human genes
0.000
description
13
239000005090
green fluorescent protein
Substances
0.000
description
13
230000007018
DNA scission
Effects
0.000
description
12
ISAKRJDGNUQOIC-UHFFFAOYSA-N
Uracil
Chemical compound
O=C1C=CNC(=O)N1
ISAKRJDGNUQOIC-UHFFFAOYSA-N
0.000
description
12
OPTASPLRGRRNAP-UHFFFAOYSA-N
cytosine
Chemical compound
NC=1C=CNC(=O)N=1
OPTASPLRGRRNAP-UHFFFAOYSA-N
0.000
description
12
238000001890
transfection
Methods
0.000
description
12
108091092236
Chimeric RNA
Proteins
0.000
description
11
108091026890
Coding region
Proteins
0.000
description
11
241000700605
Viruses
Species
0.000
description
11
230000004927
fusion
Effects
0.000
description
11
230000000670
limiting effect
Effects
0.000
description
11
210000001778
pluripotent stem cell
Anatomy
0.000
description
10
238000006467
substitution reaction
Methods
0.000
description
10
108020004635
Complementary DNA
Proteins
0.000
description
9
102000004533
Endonucleases
Human genes
0.000
description
9
108010042407
Endonucleases
Proteins
0.000
description
9
108091027544
Subgenomic mRNA
Proteins
0.000
description
9
108091028113
Trans-activating crRNA
Proteins
0.000
description
9
125000000217
alkyl group
Chemical group
0.000
description
9
238000012217
deletion
Methods
0.000
description
9
230000037430
deletion
Effects
0.000
description
9
125000000623
heterocyclic group
Chemical group
0.000
description
9
230000003993
interaction
Effects
0.000
description
9
239000000463
material
Substances
0.000
description
9
230000011987
methylation
Effects
0.000
description
9
238000007069
methylation reaction
Methods
0.000
description
9
239000002777
nucleoside
Substances
0.000
description
9
238000011160
research
Methods
0.000
description
9
210000001519
tissue
Anatomy
0.000
description
9
241000701022
Cytomegalovirus
Species
0.000
description
8
241000700584
Simplexvirus
Species
0.000
description
8
230000003213
activating effect
Effects
0.000
description
8
125000000539
amino acid group
Chemical group
0.000
description
8
210000004263
induced pluripotent stem cell
Anatomy
0.000
description
8
238000003780
insertion
Methods
0.000
description
8
230000037431
insertion
Effects
0.000
description
8
125000004573
morpholin-4-yl group
Chemical group
N1(CCOCC1)*
0.000
description
8
210000002569
neuron
Anatomy
0.000
description
8
238000011282
treatment
Methods
0.000
description
8
108091023037
Aptamer
Proteins
0.000
description
7
238000010446
CRISPR interference
Methods
0.000
description
7
108091093037
Peptide nucleic acid
Proteins
0.000
description
7
150000001408
amides
Chemical class
0.000
description
7
210000003763
chloroplast
Anatomy
0.000
description
7
239000003814
drug
Substances
0.000
description
7
125000003835
nucleoside group
Chemical group
0.000
description
7
210000004940
nucleus
Anatomy
0.000
description
7
230000010741
sumoylation
Effects
0.000
description
7
229940035893
uracil
Drugs
0.000
description
7
229930024421
Adenine
Natural products
0.000
description
6
102100034349
Integrase
Human genes
0.000
description
6
229920002873
Polyethylenimine
Polymers
0.000
description
6
JLCPHMBAVCMARE-UHFFFAOYSA-N
[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
Polymers
Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O
JLCPHMBAVCMARE-UHFFFAOYSA-N
0.000
description
6
229960000643
adenine
Drugs
0.000
description
6
239000001506
calcium phosphate
Substances
0.000
description
6
229910000389
calcium phosphate
Inorganic materials
0.000
description
6
235000011010
calcium phosphates
Nutrition
0.000
description
6
230000003197
catalytic effect
Effects
0.000
description
6
230000001413
cellular effect
Effects
0.000
description
6
239000002299
complementary DNA
Substances
0.000
description
6
229940104302
cytosine
Drugs
0.000
description
6
229940079593
drug
Drugs
0.000
description
6
239000003623
enhancer
Substances
0.000
description
6
235000019688
fish
Nutrition
0.000
description
6
238000010353
genetic engineering
Methods
0.000
description
6
230000003278
mimic effect
Effects
0.000
description
6
238000001556
precipitation
Methods
0.000
description
6
230000008439
repair process
Effects
0.000
description
6
RWQNBRDOKXIBIV-UHFFFAOYSA-N
thymine
Chemical compound
CC1=CNC(=O)NC1=O
RWQNBRDOKXIBIV-UHFFFAOYSA-N
0.000
description
6
QORWJWZARLRLPR-UHFFFAOYSA-H
tricalcium bis(phosphate)
Chemical compound
[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
QORWJWZARLRLPR-UHFFFAOYSA-H
0.000
description
6
UHDGCWIWMRVCDJ-UHFFFAOYSA-N
1-beta-D-Xylofuranosyl-NH-Cytosine
Natural products
O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N
0.000
description
5
GFFGJBXGBJISGV-UHFFFAOYSA-N
Adenine
Chemical compound
NC1=NC=NC2=C1N=CN2
GFFGJBXGBJISGV-UHFFFAOYSA-N
0.000
description
5
UHDGCWIWMRVCDJ-PSQAKQOGSA-N
Cytidine
Natural products
O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N
0.000
description
5
230000004568
DNA-binding
Effects
0.000
description
5
241000725303
Human immunodeficiency virus
Species
0.000
description
5
241000588650
Neisseria meningitidis
Species
0.000
description
5
108091008103
RNA aptamers
Proteins
0.000
description
5
108020004422
Riboswitch
Proteins
0.000
description
5
241000194020
Streptococcus thermophilus
Species
0.000
description
5
230000000692
anti-sense effect
Effects
0.000
description
5
239000011575
calcium
Substances
0.000
description
5
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N
cytidine
Chemical compound
O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N
0.000
description
5
230000006870
function
Effects
0.000
description
5
125000003843
furanosyl group
Chemical group
0.000
description
5
230000002068
genetic effect
Effects
0.000
description
5
230000012010
growth
Effects
0.000
description
5
230000021121
meiosis
Effects
0.000
description
5
230000011278
mitosis
Effects
0.000
description
5
125000002467
phosphate group
Chemical group
[H]OP(=O)(O[H])O[*]
0.000
description
5
125000001424
substituent group
Chemical group
0.000
description
5
239000013603
viral vector
Substances
0.000
description
5
230000003612
virological effect
Effects
0.000
description
5
PEHVGBZKEYRQSX-UHFFFAOYSA-N
7-deaza-adenine
Chemical compound
NC1=NC=NC2=C1C=CN2
PEHVGBZKEYRQSX-UHFFFAOYSA-N
0.000
description
4
241000283690
Bos taurus
Species
0.000
description
4
108020004705
Codon
Proteins
0.000
description
4
108090000626
DNA-directed RNA polymerases
Proteins
0.000
description
4
102000004163
DNA-directed RNA polymerases
Human genes
0.000
description
4
241000702421
Dependoparvovirus
Species
0.000
description
4
241000714474
Rous sarcoma virus
Species
0.000
description
4
206010039491
Sarcoma
Diseases
0.000
description
4
108020004566
Transfer RNA
Proteins
0.000
description
4
235000004279
alanine
Nutrition
0.000
description
4
125000000304
alkynyl group
Chemical group
0.000
description
4
235000009697
arginine
Nutrition
0.000
description
4
125000000637
arginyl group
Chemical class
N[C@@H](CCCNC(N)=N)C(=O)*
0.000
description
4
230000033228
biological regulation
Effects
0.000
description
4
239000003795
chemical substances by application
Substances
0.000
description
4
HVYWMOMLDIMFJA-DPAQBDIFSA-N
cholesterol
Chemical group
C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2
HVYWMOMLDIMFJA-DPAQBDIFSA-N
0.000
description
4
230000002759
chromosomal effect
Effects
0.000
description
4
230000021615
conjugation
Effects
0.000
description
4
230000001419
dependent effect
Effects
0.000
description
4
238000011161
development
Methods
0.000
description
4
230000018109
developmental process
Effects
0.000
description
4
210000001671
embryonic stem cell
Anatomy
0.000
description
4
102000015694
estrogen receptors
Human genes
0.000
description
4
108010038795
estrogen receptors
Proteins
0.000
description
4
102000034287
fluorescent proteins
Human genes
0.000
description
4
108091006047
fluorescent proteins
Proteins
0.000
description
4
239000012634
fragment
Substances
0.000
description
4
229920002521
macromolecule
Polymers
0.000
description
4
239000000178
monomer
Substances
0.000
description
4
238000002887
multiple sequence alignment
Methods
0.000
description
4
210000003205
muscle
Anatomy
0.000
description
4
239000002105
nanoparticle
Substances
0.000
description
4
125000004437
phosphorous atom
Chemical group
0.000
description
4
229910052698
phosphorus
Inorganic materials
0.000
description
4
229920000642
polymer
Polymers
0.000
description
4
230000008569
process
Effects
0.000
description
4
230000005783
single-strand break
Effects
0.000
description
4
238000003786
synthesis reaction
Methods
0.000
description
4
241001430294
unidentified retrovirus
Species
0.000
description
4
RAVVEEJGALCVIN-AGVBWZICSA-N
(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-(diamino
Chemical compound
NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1
RAVVEEJGALCVIN-AGVBWZICSA-N
0.000
description
3
LRSASMSXMSNRBT-UHFFFAOYSA-N
5-methylcytosine
Chemical compound
CC1=CNC(=O)N=C1N
LRSASMSXMSNRBT-UHFFFAOYSA-N
0.000
description
3
KDCGOANMDULRCW-UHFFFAOYSA-N
7H-purine
Chemical compound
N1=CNC2=NC=NC2=C1
KDCGOANMDULRCW-UHFFFAOYSA-N
0.000
description
3
239000004475
Arginine
Substances
0.000
description
3
108010008532
Deoxyribonuclease I
Proteins
0.000
description
3
102000007260
Deoxyribonuclease I
Human genes
0.000
description
3
229920002307
Dextran
Polymers
0.000
description
3
108020005004
Guide RNA
Proteins
0.000
description
3
HVLSXIKZNLPZJJ-TXZCQADKSA-N
HA peptide
Chemical compound
C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1
HVLSXIKZNLPZJJ-TXZCQADKSA-N
0.000
description
3
108700000788
Human immunodeficiency virus 1 tat peptide (47-57)
Proteins
0.000
description
3
QNAYBMKLOCPYGJ-REOHCLBHSA-N
L-alanine
Chemical compound
C[C@H](N)C(O)=O
QNAYBMKLOCPYGJ-REOHCLBHSA-N
0.000
description
3
201000009906
Meningitis
Diseases
0.000
description
3
102000007474
Multiprotein Complexes
Human genes
0.000
description
3
108010085220
Multiprotein Complexes
Proteins
0.000
description
3
241000202964
Mycoplasma mobile
Species
0.000
description
3
238000012228
RNA interference-mediated gene silencing
Methods
0.000
description
3
230000021736
acetylation
Effects
0.000
description
3
238000006640
acetylation reaction
Methods
0.000
description
3
239000002253
acid
Substances
0.000
description
3
238000013459
approach
Methods
0.000
description
3
229910052799
carbon
Inorganic materials
0.000
description
3
210000004413
cardiac myocyte
Anatomy
0.000
description
3
230000004186
co-expression
Effects
0.000
description
3
230000007423
decrease
Effects
0.000
description
3
230000003247
decreasing effect
Effects
0.000
description
3
230000009977
dual effect
Effects
0.000
description
3
210000003981
ectoderm
Anatomy
0.000
description
3
238000004520
electroporation
Methods
0.000
description
3
210000001900
endoderm
Anatomy
0.000
description
3
238000012224
gene deletion
Methods
0.000
description
3
230000009368
gene silencing by RNA
Effects
0.000
description
3
238000001415
gene therapy
Methods
0.000
description
3
125000005842
heteroatom
Chemical group
0.000
description
3
230000006195
histone acetylation
Effects
0.000
description
3
125000002887
hydroxy group
Chemical group
[H]O*
0.000
description
3
208000015181
infectious disease
Diseases
0.000
description
3
230000003834
intracellular effect
Effects
0.000
description
3
238000001638
lipofection
Methods
0.000
description
3
239000002502
liposome
Substances
0.000
description
3
230000007246
mechanism
Effects
0.000
description
3
239000012528
membrane
Substances
0.000
description
3
210000004379
membrane
Anatomy
0.000
description
3
210000003716
mesoderm
Anatomy
0.000
description
3
238000000520
microinjection
Methods
0.000
description
3
210000003470
mitochondria
Anatomy
0.000
description
3
230000002438
mitochondrial effect
Effects
0.000
description
3
238000010369
molecular cloning
Methods
0.000
description
3
210000003463
organelle
Anatomy
0.000
description
3
239000002245
particle
Substances
0.000
description
3
230000003285
pharmacodynamic effect
Effects
0.000
description
3
238000002360
preparation method
Methods
0.000
description
3
150000003212
purines
Chemical class
0.000
description
3
230000008672
reprogramming
Effects
0.000
description
3
230000001177
retroviral effect
Effects
0.000
description
3
230000002441
reversible effect
Effects
0.000
description
3
150000003839
salts
Chemical class
0.000
description
3
230000001743
silencing effect
Effects
0.000
description
3
229940113082
thymine
Drugs
0.000
description
3
238000010361
transduction
Methods
0.000
description
3
230000026683
transduction
Effects
0.000
description
3
230000009466
transformation
Effects
0.000
description
3
238000013519
translation
Methods
0.000
description
3
230000034512
ubiquitination
Effects
0.000
description
3
238000010798
ubiquitination
Methods
0.000
description
3
241000701161
unidentified adenovirus
Species
0.000
description
3
241001515965
unidentified phage
Species
0.000
description
3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N
(+)-Biotin
Chemical group
N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21
YBJHBAHKTGYVGT-ZKWXMUAHSA-N
0.000
description
2
PIINGYXNCHTJTF-UHFFFAOYSA-N
2-(2-azaniumylethylamino)acetate
Chemical group
NCCNCC(O)=O
PIINGYXNCHTJTF-UHFFFAOYSA-N
0.000
description
2
FZWGECJQACGGTI-UHFFFAOYSA-N
2-amino-7-methyl-1,7-dihydro-6H-purin-6-one
Chemical compound
NC1=NC(O)=C2N(C)C=NC2=N1
FZWGECJQACGGTI-UHFFFAOYSA-N
0.000
description
2
ICSNLGPSRYBMBD-UHFFFAOYSA-N
2-aminopyridine
Chemical compound
NC1=CC=CC=N1
ICSNLGPSRYBMBD-UHFFFAOYSA-N
0.000
description
2
RYVNIFSIEDRLSJ-UHFFFAOYSA-N
5-(hydroxymethyl)cytosine
Chemical compound
NC=1NC(=O)N=CC=1CO
RYVNIFSIEDRLSJ-UHFFFAOYSA-N
0.000
description
2
HCGHYQLFMPXSDU-UHFFFAOYSA-N
7-methyladenine
Chemical compound
C1=NC(N)=C2N(C)C=NC2=N1
HCGHYQLFMPXSDU-UHFFFAOYSA-N
0.000
description
2
UJOBWOGCFQCDNV-UHFFFAOYSA-N
9H-carbazole
Chemical compound
C1=CC=C2C3=CC=CC=C3NC2=C1
UJOBWOGCFQCDNV-UHFFFAOYSA-N
0.000
description
2
MSSXOMSJDRHRMC-UHFFFAOYSA-N
9H-purine-2,6-diamine
Chemical compound
NC1=NC(N)=C2NC=NC2=N1
MSSXOMSJDRHRMC-UHFFFAOYSA-N
0.000
description
2
LRFVTYWOQMYALW-UHFFFAOYSA-N
9H-xanthine
Chemical compound
O=C1NC(=O)NC2=C1NC=N2
LRFVTYWOQMYALW-UHFFFAOYSA-N
0.000
description
2
102000007469
Actins
Human genes
0.000
description
2
108010085238
Actins
Proteins
0.000
description
2
102000002260
Alkaline Phosphatase
Human genes
0.000
description
2
108020004774
Alkaline Phosphatase
Proteins
0.000
description
2
241000714230
Avian leukemia virus
Species
0.000
description
2
206010006187
Breast cancer
Diseases
0.000
description
2
208000026310
Breast neoplasm
Diseases
0.000
description
2
241000589875
Campylobacter jejuni
Species
0.000
description
2
230000007067
DNA methylation
Effects
0.000
description
2
102000052510
DNA-Binding Proteins
Human genes
0.000
description
2
101710096438
DNA-binding protein
Proteins
0.000
description
2
241000255581
Drosophila <fruit fly, genus>
Species
0.000
description
2
241000991587
Enterovirus C
Species
0.000
description
2
108700028146
Genetic Enhancer Elements
Proteins
0.000
description
2
DHMQDGOQFOQNFH-UHFFFAOYSA-N
Glycine
Chemical compound
NCC(O)=O
DHMQDGOQFOQNFH-UHFFFAOYSA-N
0.000
description
2
101710154606
Hemagglutinin
Proteins
0.000
description
2
102000003893
Histone acetyltransferases
Human genes
0.000
description
2
108090000246
Histone acetyltransferases
Proteins
0.000
description
2
101001062864
Homo sapiens Fatty acid-binding protein, adipocyte
Proteins
0.000
description
2
101001001272
Homo sapiens Prostatic acid phosphatase
Proteins
0.000
description
2
241000589242
Legionella pneumophila
Species
0.000
description
2
241000713666
Lentivirus
Species
0.000
description
2
241000186805
Listeria innocua
Species
0.000
description
2
241000714177
Murine leukemia virus
Species
0.000
description
2
101000969137
Mus musculus Metallothionein-1
Proteins
0.000
description
2
208000009869
Neu-Laxova syndrome
Diseases
0.000
description
2
108010077850
Nuclear Localization Signals
Proteins
0.000
description
2
108091005461
Nucleic proteins
Proteins
0.000
description
2
101710093908
Outer capsid protein VP4
Proteins
0.000
description
2
101710135467
Outer capsid protein sigma-1
Proteins
0.000
description
2
102000012288
Phosphopyruvate Hydratase
Human genes
0.000
description
2
108010022181
Phosphopyruvate Hydratase
Proteins
0.000
description
2
108091036407
Polyadenylation
Proteins
0.000
description
2
241000288906
Primates
Species
0.000
description
2
102100035703
Prostatic acid phosphatase
Human genes
0.000
description
2
101710176177
Protein A56
Proteins
0.000
description
2
102000055027
Protein Methyltransferases
Human genes
0.000
description
2
108700040121
Protein Methyltransferases
Proteins
0.000
description
2
238000003559
RNA-seq method
Methods
0.000
description
2
108091081062
Repeated sequence (DNA)
Proteins
0.000
description
2
102100038247
Retinol-binding protein 3
Human genes
0.000
description
2
108091006300
SLC2A4
Proteins
0.000
description
2
108020004682
Single-Stranded DNA
Proteins
0.000
description
2
206010055047
Splenic necrosis
Diseases
0.000
description
2
108091081024
Start codon
Proteins
0.000
description
2
241000194019
Streptococcus mutans
Species
0.000
description
2
239000004098
Tetracycline
Substances
0.000
description
2
RYYWUUFWQRZTIU-UHFFFAOYSA-N
Thiophosphoric acid
Chemical class
OP(O)(S)=O
RYYWUUFWQRZTIU-UHFFFAOYSA-N
0.000
description
2
IQFYYKKMVGJFEH-XLPZGREQSA-N
Thymidine
Chemical compound
O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1
IQFYYKKMVGJFEH-XLPZGREQSA-N
0.000
description
2
102000006601
Thymidine Kinase
Human genes
0.000
description
2
108020004440
Thymidine kinase
Proteins
0.000
description
2
108020004417
Untranslated RNA
Proteins
0.000
description
2
102000039634
Untranslated RNA
Human genes
0.000
description
2
241000700618
Vaccinia virus
Species
0.000
description
2
150000007513
acids
Chemical class
0.000
description
2
DZBUGLKDJFMEHC-UHFFFAOYSA-N
acridine
Chemical group
C1=CC=CC2=CC3=CC=CC=C3N=C21
DZBUGLKDJFMEHC-UHFFFAOYSA-N
0.000
description
2
210000001789
adipocyte
Anatomy
0.000
description
2
125000001931
aliphatic group
Chemical group
0.000
description
2
125000003342
alkenyl group
Chemical group
0.000
description
2
ODKSFYDXXFIFQN-UHFFFAOYSA-N
arginine
Natural products
OC(=O)C(N)CCCNC(N)=N
ODKSFYDXXFIFQN-UHFFFAOYSA-N
0.000
description
2
230000031018
biological processes and functions
Effects
0.000
description
2
210000001185
bone marrow
Anatomy
0.000
description
2
210000004556
brain
Anatomy
0.000
description
2
238000010804
cDNA synthesis
Methods
0.000
description
2
125000001369
canonical nucleoside group
Chemical group
0.000
description
2
125000004432
carbon atom
Chemical group
C*
0.000
description
2
230000000747
cardiac effect
Effects
0.000
description
2
230000015556
catabolic process
Effects
0.000
description
2
210000000170
cell membrane
Anatomy
0.000
description
2
230000008859
change
Effects
0.000
description
2
235000012000
cholesterol
Nutrition
0.000
description
2
239000013611
chromosomal DNA
Substances
0.000
description
2
208000037516
chromosome inversion disease
Diseases
0.000
description
2
238000010276
construction
Methods
0.000
description
2
125000000753
cycloalkyl group
Chemical group
0.000
description
2
230000006378
damage
Effects
0.000
description
2
230000006196
deacetylation
Effects
0.000
description
2
238000003381
deacetylation reaction
Methods
0.000
description
2
238000006731
degradation reaction
Methods
0.000
description
2
238000001514
detection method
Methods
0.000
description
2
238000009826
distribution
Methods
0.000
description
2
238000001917
fluorescence detection
Methods
0.000
description
2
OVBPIULPVIDEAO-LBPRGKRZSA-N
folic acid
Chemical group
C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1
OVBPIULPVIDEAO-LBPRGKRZSA-N
0.000
description
2
238000012239
gene modification
Methods
0.000
description
2
230000030279
gene silencing
Effects
0.000
description
2
230000005017
genetic modification
Effects
0.000
description
2
235000013617
genetically modified food
Nutrition
0.000
description
2
210000001654
germ layer
Anatomy
0.000
description
2
230000003781
hair follicle cycle
Effects
0.000
description
2
125000001475
halogen functional group
Chemical group
0.000
description
2
239000000185
hemagglutinin
Substances
0.000
description
2
HNDVDQJCIGZPNO-UHFFFAOYSA-N
histidine
Natural products
OC(=O)C(N)CC1=CN=CN1
HNDVDQJCIGZPNO-UHFFFAOYSA-N
0.000
description
2
FDGQSTZJBFJUBT-UHFFFAOYSA-N
hypoxanthine
Chemical compound
O=C1NC=NC2=C1NC=N2
FDGQSTZJBFJUBT-UHFFFAOYSA-N
0.000
description
2
238000010348
incorporation
Methods
0.000
description
2
230000006698
induction
Effects
0.000
description
2
230000000977
initiatory effect
Effects
0.000
description
2
108010048996
interstitial retinol-binding protein
Proteins
0.000
description
2
229960000310
isoleucine
Drugs
0.000
description
2
BPHPUYQFMNQIOC-NXRLNHOXSA-N
isopropyl beta-D-thiogalactopyranoside
Chemical compound
CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
BPHPUYQFMNQIOC-NXRLNHOXSA-N
0.000
description
2
238000002372
labelling
Methods
0.000
description
2
150000002632
lipids
Chemical group
0.000
description
2
210000001161
mammalian embryo
Anatomy
0.000
description
2
239000003550
marker
Substances
0.000
description
2
229910052751
metal
Inorganic materials
0.000
description
2
239000002184
metal
Substances
0.000
description
2
125000000325
methylidene group
Chemical group
[H]C([H])=*
0.000
description
2
238000002703
mutagenesis
Methods
0.000
description
2
231100000350
mutagenesis
Toxicity
0.000
description
2
229910052757
nitrogen
Inorganic materials
0.000
description
2
150000003833
nucleoside derivatives
Chemical class
0.000
description
2
230000001590
oxidative effect
Effects
0.000
description
2
RDOWQLZANAYVLL-UHFFFAOYSA-N
phenanthridine
Chemical group
C1=CC=C2C3=CC=CC=C3C=NC2=C1
RDOWQLZANAYVLL-UHFFFAOYSA-N
0.000
description
2
150000004713
phosphodiesters
Chemical class
0.000
description
2
150000003904
phospholipids
Chemical group
0.000
description
2
150000008298
phosphoramidates
Chemical class
0.000
description
2
150000008300
phosphoramidites
Chemical class
0.000
description
2
108091008695
photoreceptors
Proteins
0.000
description
2
229920000724
poly(L-arginine) polymer
Polymers
0.000
description
2
230000008488
polyadenylation
Effects
0.000
description
2
229920000768
polyamine
Polymers
0.000
description
2
229920000447
polyanionic polymer
Polymers
0.000
description
2
108010011110
polyarginine
Proteins
0.000
description
2
229920001223
polyethylene glycol
Polymers
0.000
description
2
238000003752
polymerase chain reaction
Methods
0.000
description
2
239000002243
precursor
Substances
0.000
description
2
238000012545
processing
Methods
0.000
description
2
239000000047
product
Substances
0.000
description
2
108020001580
protein domains
Proteins
0.000
description
2
238000000746
purification
Methods
0.000
description
2
150000003230
pyrimidines
Chemical class
0.000
description
2
230000010076
replication
Effects
0.000
description
2
230000000717
retained effect
Effects
0.000
description
2
230000035939
shock
Effects
0.000
description
2
150000003384
small molecules
Chemical class
0.000
description
2
210000002460
smooth muscle
Anatomy
0.000
description
2
239000000243
solution
Substances
0.000
description
2
150000003431
steroids
Chemical class
0.000
description
2
239000000126
substance
Substances
0.000
description
2
150000008163
sugars
Chemical class
0.000
description
2
229910052717
sulfur
Inorganic materials
0.000
description
2
208000024891
symptom
Diseases
0.000
description
2
229960002180
tetracycline
Drugs
0.000
description
2
229930101283
tetracycline
Natural products
0.000
description
2
235000019364
tetracycline
Nutrition
0.000
description
2
150000003522
tetracyclines
Chemical class
0.000
description
2
230000001225
therapeutic effect
Effects
0.000
description
2
230000005026
transcription initiation
Effects
0.000
description
2
230000014621
translational initiation
Effects
0.000
description
2
239000004474
valine
Substances
0.000
description
2
108091005957
yellow fluorescent proteins
Proteins
0.000
description
2
MTCFGRXMJLQNBG-REOHCLBHSA-N
(2S)-2-Amino-3-hydroxypropansäure
Chemical compound
OC[C@H](N)C(O)=O
MTCFGRXMJLQNBG-REOHCLBHSA-N
0.000
description
1
YIMATHOGWXZHFX-WCTZXXKLSA-N
(2r,3r,4r,5r)-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolane-2,4-diol
Chemical compound
COCCO[C@H]1[C@H](O)O[C@H](CO)[C@H]1O
YIMATHOGWXZHFX-WCTZXXKLSA-N
0.000
description
1
BEJKOYIMCGMNRB-GRHHLOCNSA-N
(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid
Chemical compound
OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1
BEJKOYIMCGMNRB-GRHHLOCNSA-N
0.000
description
1
LAQPKDLYOBZWBT-NYLDSJSYSA-N
(2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox
Chemical compound
O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1
LAQPKDLYOBZWBT-NYLDSJSYSA-N
0.000
description
1
BHQCQFFYRZLCQQ-UHFFFAOYSA-N
(3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid
Natural products
OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2
BHQCQFFYRZLCQQ-UHFFFAOYSA-N
0.000
description
1
QGVQZRDQPDLHHV-DPAQBDIFSA-N
(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3-thiol
Chemical compound
C1C=C2C[C@@H](S)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2
QGVQZRDQPDLHHV-DPAQBDIFSA-N
0.000
description
1
SGKRLCUYIXIAHR-AKNGSSGZSA-N
(4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide
Chemical compound
C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O
SGKRLCUYIXIAHR-AKNGSSGZSA-N
0.000
description
1
UFSCXDAOCAIFOG-UHFFFAOYSA-N
1,10-dihydropyrimido[5,4-b][1,4]benzothiazin-2-one
Chemical compound
S1C2=CC=CC=C2N=C2C1=CNC(=O)N2
UFSCXDAOCAIFOG-UHFFFAOYSA-N
0.000
description
1
PTFYZDMJTFMPQW-UHFFFAOYSA-N
1,10-dihydropyrimido[5,4-b][1,4]benzoxazin-2-one
Chemical compound
O1C2=CC=CC=C2N=C2C1=CNC(=O)N2
PTFYZDMJTFMPQW-UHFFFAOYSA-N
0.000
description
1
FYADHXFMURLYQI-UHFFFAOYSA-N
1,2,4-triazine
Chemical class
C1=CN=NC=N1
FYADHXFMURLYQI-UHFFFAOYSA-N
0.000
description
1
WJFKNYWRSNBZNX-UHFFFAOYSA-N
10H-phenothiazine
Chemical compound
C1=CC=C2NC3=CC=CC=C3SC2=C1
WJFKNYWRSNBZNX-UHFFFAOYSA-N
0.000
description
1
TZMSYXZUNZXBOL-UHFFFAOYSA-N
10H-phenoxazine
Chemical compound
C1=CC=C2NC3=CC=CC=C3OC2=C1
TZMSYXZUNZXBOL-UHFFFAOYSA-N
0.000
description
1
NCYCYZXNIZJOKI-IOUUIBBYSA-N
11-cis-retinal
Chemical compound
O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
NCYCYZXNIZJOKI-IOUUIBBYSA-N
0.000
description
1
UHUHBFMZVCOEOV-UHFFFAOYSA-N
1h-imidazo[4,5-c]pyridin-4-amine
Chemical compound
NC1=NC=CC2=C1N=CN2
UHUHBFMZVCOEOV-UHFFFAOYSA-N
0.000
description
1
VEPOHXYIFQMVHW-XOZOLZJESA-N
2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine
Chemical group
OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1
VEPOHXYIFQMVHW-XOZOLZJESA-N
0.000
description
1
QSHACTSJHMKXTE-UHFFFAOYSA-N
2-(2-aminopropyl)-7h-purin-6-amine
Chemical compound
CC(N)CC1=NC(N)=C2NC=NC2=N1
QSHACTSJHMKXTE-UHFFFAOYSA-N
0.000
description
1
KISWVXRQTGLFGD-UHFFFAOYSA-N
2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p
Chemical compound
C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1
KISWVXRQTGLFGD-UHFFFAOYSA-N
0.000
description
1
JRYMOPZHXMVHTA-DAGMQNCNSA-N
2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one
Chemical compound
C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
JRYMOPZHXMVHTA-DAGMQNCNSA-N
0.000
description
1
WKMPTBDYDNUJLF-UHFFFAOYSA-N
2-fluoroadenine
Chemical compound
NC1=NC(F)=NC2=C1N=CN2
WKMPTBDYDNUJLF-UHFFFAOYSA-N
0.000
description
1
125000004200
2-methoxyethyl group
Chemical group
[H]C([H])([H])OC([H])([H])C([H])([H])*
0.000
description
1
125000003903
2-propenyl group
Chemical group
[H]C([*])([H])C([H])=C([H])[H]
0.000
description
1
PDBUTMYDZLUVCP-UHFFFAOYSA-N
3,4-dihydro-1,4-benzoxazin-2-one
Chemical compound
C1=CC=C2OC(=O)CNC2=C1
PDBUTMYDZLUVCP-UHFFFAOYSA-N
0.000
description
1
GOLORTLGFDVFDW-UHFFFAOYSA-N
3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one
Chemical group
C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1
GOLORTLGFDVFDW-UHFFFAOYSA-N
0.000
description
1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N
4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid
Chemical compound
C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N
0.000
description
1
OVONXEQGWXGFJD-UHFFFAOYSA-N
4-sulfanylidene-1h-pyrimidin-2-one
Chemical compound
SC=1C=CNC(=O)N=1
OVONXEQGWXGFJD-UHFFFAOYSA-N
0.000
description
1
102000040125
5-hydroxytryptamine receptor family
Human genes
0.000
description
1
108091032151
5-hydroxytryptamine receptor family
Proteins
0.000
description
1
ZLAQATDNGLKIEV-UHFFFAOYSA-N
5-methyl-2-sulfanylidene-1h-pyrimidin-4-one
Chemical compound
CC1=CNC(=S)NC1=O
ZLAQATDNGLKIEV-UHFFFAOYSA-N
0.000
description
1
UJBCLAXPPIDQEE-UHFFFAOYSA-N
5-prop-1-ynyl-1h-pyrimidine-2,4-dione
Chemical compound
CC#CC1=CNC(=O)NC1=O
UJBCLAXPPIDQEE-UHFFFAOYSA-N
0.000
description
1
KXBCLNRMQPRVTP-UHFFFAOYSA-N
6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one
Chemical compound
O=C1NC(N)=CC2=C1N=CN2
KXBCLNRMQPRVTP-UHFFFAOYSA-N
0.000
description
1
DCPSTSVLRXOYGS-UHFFFAOYSA-N
6-amino-1h-pyrimidine-2-thione
Chemical compound
NC1=CC=NC(S)=N1
DCPSTSVLRXOYGS-UHFFFAOYSA-N
0.000
description
1
QNNARSZPGNJZIX-UHFFFAOYSA-N
6-amino-5-prop-1-ynyl-1h-pyrimidin-2-one
Chemical compound
CC#CC1=CNC(=O)N=C1N
QNNARSZPGNJZIX-UHFFFAOYSA-N
0.000
description
1
CNNSWSHYGANWBM-UHFFFAOYSA-N
6-chloro-2,3-dimethylquinoxaline
Chemical compound
C1=C(Cl)C=C2N=C(C)C(C)=NC2=C1
CNNSWSHYGANWBM-UHFFFAOYSA-N
0.000
description
1
NJBMMMJOXRZENQ-UHFFFAOYSA-N
6H-pyrrolo[2,3-f]quinoline
Chemical compound
c1cc2ccc3[nH]cccc3c2n1
NJBMMMJOXRZENQ-UHFFFAOYSA-N
0.000
description
1
LOSIULRWFAEMFL-UHFFFAOYSA-N
7-deazaguanine
Chemical compound
O=C1NC(N)=NC2=C1CC=N2
LOSIULRWFAEMFL-UHFFFAOYSA-N
0.000
description
1
HRYKDUPGBWLLHO-UHFFFAOYSA-N
8-azaadenine
Chemical compound
NC1=NC=NC2=NNN=C12
HRYKDUPGBWLLHO-UHFFFAOYSA-N
0.000
description
1
LPXQRXLUHJKZIE-UHFFFAOYSA-N
8-azaguanine
Chemical compound
NC1=NC(O)=C2NN=NC2=N1
LPXQRXLUHJKZIE-UHFFFAOYSA-N
0.000
description
1
229960005508
8-azaguanine
Drugs
0.000
description
1
208000035657
Abasia
Diseases
0.000
description
1
241001134630
Acidothermus cellulolyticus
Species
0.000
description
1
102000011690
Adiponectin
Human genes
0.000
description
1
108010076365
Adiponectin
Proteins
0.000
description
1
108020005098
Anticodon
Proteins
0.000
description
1
101000993093
Arabidopsis thaliana Heat stress transcription factor B-2a
Proteins
0.000
description
1
102000003823
Aromatic-L-amino-acid decarboxylases
Human genes
0.000
description
1
108090000121
Aromatic-L-amino-acid decarboxylases
Proteins
0.000
description
1
BHELIUBJHYAEDK-OAIUPTLZSA-N
Aspoxicillin
Chemical compound
C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1
BHELIUBJHYAEDK-OAIUPTLZSA-N
0.000
description
1
241000606124
Bacteroides fragilis
Species
0.000
description
1
DWRXFEITVBNRMK-UHFFFAOYSA-N
Beta-D-1-Arabinofuranosylthymine
Natural products
O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1
DWRXFEITVBNRMK-UHFFFAOYSA-N
0.000
description
1
241000186000
Bifidobacterium
Species
0.000
description
1
241000186016
Bifidobacterium bifidum
Species
0.000
description
1
102100035875
C-C chemokine receptor type 5
Human genes
0.000
description
1
101710149870
C-C chemokine receptor type 5
Proteins
0.000
description
1
125000006374
C2-C10 alkenyl group
Chemical group
0.000
description
1
102000049320
CD36
Human genes
0.000
description
1
108010045374
CD36 Antigens
Proteins
0.000
description
1
101100421200
Caenorhabditis elegans sep-1 gene
Proteins
0.000
description
1
241000282472
Canis lupus familiaris
Species
0.000
description
1
102000014914
Carrier Proteins
Human genes
0.000
description
1
108010078791
Carrier Proteins
Proteins
0.000
description
1
102100035605
Cas scaffolding protein family member 4
Human genes
0.000
description
1
108010051109
Cell-Penetrating Peptides
Proteins
0.000
description
1
102000020313
Cell-Penetrating Peptides
Human genes
0.000
description
1
239000004380
Cholic acid
Substances
0.000
description
1
102000003706
Complement factor D
Human genes
0.000
description
1
108090000059
Complement factor D
Proteins
0.000
description
1
108020004394
Complementary RNA
Proteins
0.000
description
1
229940126062
Compound A
Drugs
0.000
description
1
241000699800
Cricetinae
Species
0.000
description
1
GUBGYTABKSRVRQ-PICCSMPSSA-N
D-Maltose
Chemical compound
O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O
GUBGYTABKSRVRQ-PICCSMPSSA-N
0.000
description
1
102100036279
DNA (cytosine-5)-methyltransferase 1
Human genes
0.000
description
1
108020003215
DNA Probes
Proteins
0.000
description
1
238000010442
DNA editing
Methods
0.000
description
1
239000003298
DNA probe
Substances
0.000
description
1
108010053770
Deoxyribonucleases
Proteins
0.000
description
1
102000016911
Deoxyribonucleases
Human genes
0.000
description
1
241000283086
Equidae
Species
0.000
description
1
241000588724
Escherichia coli
Species
0.000
description
1
241000206602
Eukaryota
Species
0.000
description
1
108060002716
Exonuclease
Proteins
0.000
description
1
241000282326
Felis catus
Species
0.000
description
1
241000605896
Fibrobacter succinogenes
Species
0.000
description
1
241000604777
Flavobacterium columnare
Species
0.000
description
1
241000589599
Francisella tularensis subsp. novicida
Species
0.000
description
1
108091004242
G-Protein-Coupled Receptor Kinase 1
Proteins
0.000
description
1
102000004437
G-Protein-Coupled Receptor Kinase 1
Human genes
0.000
description
1
241000968725
Gammaproteobacteria bacterium
Species
0.000
description
1
206010064571
Gene mutation
Diseases
0.000
description
1
108700039691
Genetic Promoter Regions
Proteins
0.000
description
1
239000004471
Glycine
Substances
0.000
description
1
NMJREATYWWNIKX-UHFFFAOYSA-N
GnRH
Chemical compound
C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1
NMJREATYWWNIKX-UHFFFAOYSA-N
0.000
description
1
102100035364
Growth/differentiation factor 3
Human genes
0.000
description
1
108050008753
HNH endonucleases
Proteins
0.000
description
1
102000000310
HNH endonucleases
Human genes
0.000
description
1
102100032606
Heat shock factor protein 1
Human genes
0.000
description
1
101710190344
Heat shock factor protein 1
Proteins
0.000
description
1
101150094793
Hes3 gene
Proteins
0.000
description
1
101150029234
Hes5 gene
Proteins
0.000
description
1
NLDMNSXOCDLTTB-UHFFFAOYSA-N
Heterophylliin A
Natural products
O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1
NLDMNSXOCDLTTB-UHFFFAOYSA-N
0.000
description
1
102000003964
Histone deacetylase
Human genes
0.000
description
1
108090000353
Histone deacetylase
Proteins
0.000
description
1
101000741445
Homo sapiens Calcitonin
Proteins
0.000
description
1
101000947106
Homo sapiens Cas scaffolding protein family member 4
Proteins
0.000
description
1
101000931098
Homo sapiens DNA (cytosine-5)-methyltransferase 1
Proteins
0.000
description
1
101001023986
Homo sapiens Growth/differentiation factor 3
Proteins
0.000
description
1
101001139134
Homo sapiens Krueppel-like factor 4
Proteins
0.000
description
1
101001030211
Homo sapiens Myc proto-oncogene protein
Proteins
0.000
description
1
101000835745
Homo sapiens Teratocarcinoma-derived growth factor 1
Proteins
0.000
description
1
101000843556
Homo sapiens Transcription factor HES-1
Proteins
0.000
description
1
101000687905
Homo sapiens Transcription factor SOX-2
Proteins
0.000
description
1
101000976622
Homo sapiens Zinc finger protein 42 homolog
Proteins
0.000
description
1
241000713772
Human immunodeficiency virus 1
Species
0.000
description
1
108700003968
Human immunodeficiency virus 1 tat peptide (49-57)
Proteins
0.000
description
1
206010020772
Hypertension
Diseases
0.000
description
1
UGQMRVRMYYASKQ-UHFFFAOYSA-N
Hypoxanthine nucleoside
Natural products
OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1
UGQMRVRMYYASKQ-UHFFFAOYSA-N
0.000
description
1
DGAQECJNVWCQMB-PUAWFVPOSA-M
Ilexoside XXIX
Chemical compound
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+]
DGAQECJNVWCQMB-PUAWFVPOSA-M
0.000
description
1
101710203526
Integrase
Proteins
0.000
description
1
101150105817
Irbp gene
Proteins
0.000
description
1
102100020677
Krueppel-like factor 4
Human genes
0.000
description
1
XUJNEKJLAYXESH-REOHCLBHSA-N
L-Cysteine
Chemical compound
SC[C@H](N)C(O)=O
XUJNEKJLAYXESH-REOHCLBHSA-N
0.000
description
1
ODKSFYDXXFIFQN-BYPYZUCNSA-P
L-argininium(2+)
Chemical compound
NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O
ODKSFYDXXFIFQN-BYPYZUCNSA-P
0.000
description
1
CKLJMWTZIZZHCS-REOHCLBHSA-N
L-aspartic acid
Chemical compound
OC(=O)[C@@H](N)CC(O)=O
CKLJMWTZIZZHCS-REOHCLBHSA-N
0.000
description
1
HNDVDQJCIGZPNO-YFKPBYRVSA-N
L-histidine
Chemical compound
OC(=O)[C@@H](N)CC1=CN=CN1
HNDVDQJCIGZPNO-YFKPBYRVSA-N
0.000
description
1
AGPKZVBTJJNPAG-WHFBIAKZSA-N
L-isoleucine
Chemical compound
CC[C@H](C)[C@H](N)C(O)=O
AGPKZVBTJJNPAG-WHFBIAKZSA-N
0.000
description
1
ROHFNLRQFUQHCH-YFKPBYRVSA-N
L-leucine
Chemical compound
CC(C)C[C@H](N)C(O)=O
ROHFNLRQFUQHCH-YFKPBYRVSA-N
0.000
description
1
KDXKERNSBIXSRK-YFKPBYRVSA-N
L-lysine
Chemical compound
NCCCC[C@H](N)C(O)=O
KDXKERNSBIXSRK-YFKPBYRVSA-N
0.000
description
1
FFEARJCKVFRZRR-BYPYZUCNSA-N
L-methionine
Chemical compound
CSCC[C@H](N)C(O)=O
FFEARJCKVFRZRR-BYPYZUCNSA-N
0.000
description
1
COLNVLDHVKWLRT-QMMMGPOBSA-N
L-phenylalanine
Chemical compound
OC(=O)[C@@H](N)CC1=CC=CC=C1
COLNVLDHVKWLRT-QMMMGPOBSA-N
0.000
description
1
AYFVYJQAPQTCCC-GBXIJSLDSA-N
L-threonine
Chemical compound
C[C@@H](O)[C@H](N)C(O)=O
AYFVYJQAPQTCCC-GBXIJSLDSA-N
0.000
description
1
QIVBCDIJIAJPQS-VIFPVBQESA-N
L-tryptophane
Chemical compound
C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1
QIVBCDIJIAJPQS-VIFPVBQESA-N
0.000
description
1
OUYCCCASQSFEME-QMMMGPOBSA-N
L-tyrosine
Chemical compound
OC(=O)[C@@H](N)CC1=CC=C(O)C=C1
OUYCCCASQSFEME-QMMMGPOBSA-N
0.000
description
1
KZSNJWFQEVHDMF-BYPYZUCNSA-N
L-valine
Chemical compound
CC(C)[C@H](N)C(O)=O
KZSNJWFQEVHDMF-BYPYZUCNSA-N
0.000
description
1
241000186606
Lactobacillus gasseri
Species
0.000
description
1
241000186869
Lactobacillus salivarius
Species
0.000
description
1
GUBGYTABKSRVRQ-QKKXKWKRSA-N
Lactose
Natural products
OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
GUBGYTABKSRVRQ-QKKXKWKRSA-N
0.000
description
1
102000016267
Leptin
Human genes
0.000
description
1
108010092277
Leptin
Proteins
0.000
description
1
URLZCHNOLZSCCA-VABKMULXSA-N
Leu-enkephalin
Chemical compound
C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1
URLZCHNOLZSCCA-VABKMULXSA-N
0.000
description
1
ROHFNLRQFUQHCH-UHFFFAOYSA-N
Leucine
Natural products
CC(C)CC(N)C(O)=O
ROHFNLRQFUQHCH-UHFFFAOYSA-N
0.000
description
1
239000000232
Lipid Bilayer
Substances
0.000
description
1
241000186781
Listeria
Species
0.000
description
1
108090000362
Lymphotoxin-beta
Proteins
0.000
description
1
241000282560
Macaca mulatta
Species
0.000
description
1
241000713333
Mouse mammary tumor virus
Species
0.000
description
1
101000976618
Mus musculus Zinc finger protein 42
Proteins
0.000
description
1
102100038895
Myc proto-oncogene protein
Human genes
0.000
description
1
241000204031
Mycoplasma
Species
0.000
description
1
102100026925
Myosin regulatory light chain 2, ventricular/cardiac muscle isoform
Human genes
0.000
description
1
OVBPIULPVIDEAO-UHFFFAOYSA-N
N-Pteroyl-L-glutaminsaeure
Chemical group
C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1
OVBPIULPVIDEAO-UHFFFAOYSA-N
0.000
description
1
108091061960
Naked DNA
Proteins
0.000
description
1
108700019961
Neoplasm Genes
Proteins
0.000
description
1
102000048850
Neoplasm Genes
Human genes
0.000
description
1
108020004485
Nonsense Codon
Proteins
0.000
description
1
REYJJPSVUYRZGE-UHFFFAOYSA-N
Octadecylamine
Chemical compound
CCCCCCCCCCCCCCCCCCN
REYJJPSVUYRZGE-UHFFFAOYSA-N
0.000
description
1
108700026244
Open Reading Frames
Proteins
0.000
description
1
229910019142
PO4
Inorganic materials
0.000
description
1
102100035423
POU domain, class 5, transcription factor 1
Human genes
0.000
description
1
101710126211
POU domain, class 5, transcription factor 1
Proteins
0.000
description
1
241000606856
Pasteurella multocida
Species
0.000
description
1
PCNDJXKNXGMECE-UHFFFAOYSA-N
Phenazine
Chemical group
C1=CC=CC2=NC3=CC=CC=C3N=C21
PCNDJXKNXGMECE-UHFFFAOYSA-N
0.000
description
1
ABLZXFCXXLZCGV-UHFFFAOYSA-N
Phosphorous acid
Chemical class
OP(O)=O
ABLZXFCXXLZCGV-UHFFFAOYSA-N
0.000
description
1
102100031574
Platelet glycoprotein 4
Human genes
0.000
description
1
101710202087
Platelet glycoprotein 4
Proteins
0.000
description
1
101150076840
PolI gene
Proteins
0.000
description
1
239000004952
Polyamide
Substances
0.000
description
1
239000002202
Polyethylene glycol
Substances
0.000
description
1
108010039918
Polylysine
Proteins
0.000
description
1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N
Potassium
Chemical compound
[K]
ZLMJMSJWJFRBEC-UHFFFAOYSA-N
0.000
description
1
102000001253
Protein Kinase
Human genes
0.000
description
1
102000044126
RNA-Binding Proteins
Human genes
0.000
description
1
108700020471
RNA-Binding Proteins
Proteins
0.000
description
1
101100016889
Rattus norvegicus Hes2 gene
Proteins
0.000
description
1
108700008625
Reporter Genes
Proteins
0.000
description
1
102000007156
Resistin
Human genes
0.000
description
1
108010047909
Resistin
Proteins
0.000
description
1
208000007014
Retinitis pigmentosa
Diseases
0.000
description
1
102100040756
Rhodopsin
Human genes
0.000
description
1
108090000820
Rhodopsin
Proteins
0.000
description
1
108090000799
Rhodopsin kinases
Proteins
0.000
description
1
108091028664
Ribonucleotide
Proteins
0.000
description
1
101150086694
SLC22A3 gene
Proteins
0.000
description
1
240000004808
Saccharomyces cerevisiae
Species
0.000
description
1
235000014680
Saccharomyces cerevisiae
Nutrition
0.000
description
1
238000012300
Sequence Analysis
Methods
0.000
description
1
MTCFGRXMJLQNBG-UHFFFAOYSA-N
Serine
Natural products
OCC(N)C(O)=O
MTCFGRXMJLQNBG-UHFFFAOYSA-N
0.000
description
1
108020004459
Small interfering RNA
Proteins
0.000
description
1
102100029937
Smoothelin
Human genes
0.000
description
1
101710151526
Smoothelin
Proteins
0.000
description
1
101000857870
Squalus acanthias Gonadoliberin
Proteins
0.000
description
1
241000191940
Staphylococcus
Species
0.000
description
1
241001147693
Staphylococcus sp.
Species
0.000
description
1
241000194017
Streptococcus
Species
0.000
description
1
241000282887
Suidae
Species
0.000
description
1
NINIDFKCEFEMDL-UHFFFAOYSA-N
Sulfur
Chemical compound
[S]
NINIDFKCEFEMDL-UHFFFAOYSA-N
0.000
description
1
UCKMPCXJQFINFW-UHFFFAOYSA-N
Sulphide
Chemical compound
[S-2]
UCKMPCXJQFINFW-UHFFFAOYSA-N
0.000
description
1
102000001435
Synapsin
Human genes
0.000
description
1
108050009621
Synapsin
Proteins
0.000
description
1
101710137500
T7 RNA polymerase
Proteins
0.000
description
1
101150052863
THY1 gene
Proteins
0.000
description
1
101710192266
Tegument protein VP22
Proteins
0.000
description
1
102100026404
Teratocarcinoma-derived growth factor 1
Human genes
0.000
description
1
206010043276
Teratoma
Diseases
0.000
description
1
AYFVYJQAPQTCCC-UHFFFAOYSA-N
Threonine
Natural products
CC(O)C(N)C(O)=O
AYFVYJQAPQTCCC-UHFFFAOYSA-N
0.000
description
1
239000004473
Threonine
Substances
0.000
description
1
230000010632
Transcription Factor Activity
Effects
0.000
description
1
102000040945
Transcription factor
Human genes
0.000
description
1
108091023040
Transcription factor
Proteins
0.000
description
1
102100030798
Transcription factor HES-1
Human genes
0.000
description
1
102100024270
Transcription factor SOX-2
Human genes
0.000
description
1
102000013534
Troponin C
Human genes
0.000
description
1
QIVBCDIJIAJPQS-UHFFFAOYSA-N
Tryptophan
Natural products
C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1
QIVBCDIJIAJPQS-UHFFFAOYSA-N
0.000
description
1
108091000117
Tyrosine 3-Monooxygenase
Proteins
0.000
description
1
102000048218
Tyrosine 3-monooxygenases
Human genes
0.000
description
1
229910052770
Uranium
Inorganic materials
0.000
description
1
KZSNJWFQEVHDMF-UHFFFAOYSA-N
Valine
Natural products
CC(C)C(N)C(O)=O
KZSNJWFQEVHDMF-UHFFFAOYSA-N
0.000
description
1
108010051583
Ventricular Myosins
Proteins
0.000
description
1
208000036142
Viral infection
Diseases
0.000
description
1
241000605939
Wolinella succinogenes
Species
0.000
description
1
208000027418
Wounds and injury
Diseases
0.000
description
1
101001029301
Xenopus tropicalis Forkhead box protein D3
Proteins
0.000
description
1
102100023550
Zinc finger protein 42 homolog
Human genes
0.000
description
1
SIIZPVYVXNXXQG-KGXOGWRBSA-N
[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-4-[[(3s,4r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-hydroxyoxolan-2-yl]methyl [(2r,4r,5r)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate
Polymers
C1=NC2=C(N)N=CN=C2N1[C@@H]1O[C@H](COP(O)(=O)OC2[C@@H](O[C@H](COP(O)(O)=O)[C@H]2O)N2C3=NC=NC(N)=C3N=C2)[C@@H](O)[C@H]1OP(O)(=O)OCC([C@@H](O)[C@H]1O)OC1N1C(N=CN=C2N)=C2N=C1
SIIZPVYVXNXXQG-KGXOGWRBSA-N
0.000
description
1
RLXCFCYWFYXTON-JTTSDREOSA-N
[(3S,8S,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] N-hexylcarbamate
Chemical group
C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(OC(=O)NCCCCCC)[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2
RLXCFCYWFYXTON-JTTSDREOSA-N
0.000
description
1
241001531188
[Eubacterium] rectale
Species
0.000
description
1
XVIYCJDWYLJQBG-UHFFFAOYSA-N
acetic acid;adamantane
Chemical compound
CC(O)=O.C1C(C2)CC3CC1CC2C3
XVIYCJDWYLJQBG-UHFFFAOYSA-N
0.000
description
1
230000002378
acidificating effect
Effects
0.000
description
1
230000009471
action
Effects
0.000
description
1
230000006978
adaptation
Effects
0.000
description
1
230000002411
adverse
Effects
0.000
description
1
125000003295
alanine group
Chemical group
N[C@@H](C)C(=O)*
0.000
description
1
150000001336
alkenes
Chemical class
0.000
description
1
125000005083
alkoxyalkoxy group
Chemical group
0.000
description
1
125000002877
alkyl aryl group
Chemical group
0.000
description
1
125000005600
alkyl phosphonate group
Chemical group
0.000
description
1
238000005576
amination reaction
Methods
0.000
description
1
125000004103
aminoalkyl group
Chemical group
0.000
description
1
125000005122
aminoalkylamino group
Chemical group
0.000
description
1
238000000137
annealing
Methods
0.000
description
1
PYKYMHQGRFAEBM-UHFFFAOYSA-N
anthraquinone
Chemical group
CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC
PYKYMHQGRFAEBM-UHFFFAOYSA-N
0.000
description
1
150000004056
anthraquinones
Chemical group
0.000
description
1
230000001775
anti-pathogenic effect
Effects
0.000
description
1
230000000840
anti-viral effect
Effects
0.000
description
1
238000011319
anticancer therapy
Methods
0.000
description
1
239000000074
antisense oligonucleotide
Substances
0.000
description
1
238000012230
antisense oligonucleotides
Methods
0.000
description
1
125000003710
aryl alkyl group
Chemical group
0.000
description
1
125000003118
aryl group
Chemical group
0.000
description
1
235000003704
aspartic acid
Nutrition
0.000
description
1
238000003556
assay
Methods
0.000
description
1
108010028263
bacteriophage T3 RNA polymerase
Proteins
0.000
description
1
230000037429
base substitution
Effects
0.000
description
1
238000002869
basic local alignment search tool
Methods
0.000
description
1
IQFYYKKMVGJFEH-UHFFFAOYSA-N
beta-L-thymidine
Natural products
O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1
IQFYYKKMVGJFEH-UHFFFAOYSA-N
0.000
description
1
OQFSQFPPLPISGP-UHFFFAOYSA-N
beta-carboxyaspartic acid
Natural products
OC(=O)C(N)C(C(O)=O)C(O)=O
OQFSQFPPLPISGP-UHFFFAOYSA-N
0.000
description
1
125000002619
bicyclic group
Chemical group
0.000
description
1
230000001588
bifunctional effect
Effects
0.000
description
1
108091008324
binding proteins
Proteins
0.000
description
1
229960002685
biotin
Drugs
0.000
description
1
239000011616
biotin
Chemical group
0.000
description
1
235000020958
biotin
Nutrition
0.000
description
1
210000004703
blastocyst inner cell mass
Anatomy
0.000
description
1
230000000903
blocking effect
Effects
0.000
description
1
244000309464
bull
Species
0.000
description
1
210000004899
c-terminal region
Anatomy
0.000
description
1
150000001720
carbohydrates
Chemical class
0.000
description
1
235000014633
carbohydrates
Nutrition
0.000
description
1
125000003178
carboxy group
Chemical group
[H]OC(*)=O
0.000
description
1
101150038500
cas9 gene
Proteins
0.000
description
1
230000021164
cell adhesion
Effects
0.000
description
1
238000004113
cell culture
Methods
0.000
description
1
239000013592
cell lysate
Substances
0.000
description
1
210000004671
cell-free system
Anatomy
0.000
description
1
230000004700
cellular uptake
Effects
0.000
description
1
210000003169
central nervous system
Anatomy
0.000
description
1
BHONFOAYRQZPKZ-LCLOTLQISA-N
chembl269478
Chemical compound
C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=CC=C1
BHONFOAYRQZPKZ-LCLOTLQISA-N
0.000
description
1
230000007073
chemical hydrolysis
Effects
0.000
description
1
BHQCQFFYRZLCQQ-OELDTZBJSA-N
cholic acid
Chemical compound
C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1
BHQCQFFYRZLCQQ-OELDTZBJSA-N
0.000
description
1
235000019416
cholic acid
Nutrition
0.000
description
1
229960002471
cholic acid
Drugs
0.000
description
1
238000002983
circular dichroism
Methods
0.000
description
1
239000003184
complementary RNA
Substances
0.000
description
1
238000004590
computer program
Methods
0.000
description
1
230000001276
controlling effect
Effects
0.000
description
1
238000007796
conventional method
Methods
0.000
description
1
238000012937
correction
Methods
0.000
description
1
101150008672
csn-1 gene
Proteins
0.000
description
1
150000001923
cyclic compounds
Chemical class
0.000
description
1
125000001995
cyclobutyl group
Chemical group
[H]C1([H])C([H])([H])C([H])(*)C1([H])[H]
0.000
description
1
125000000596
cyclohexenyl group
Chemical group
C1(=CCCCC1)*
0.000
description
1
XUJNEKJLAYXESH-UHFFFAOYSA-N
cysteine
Natural products
SCC(N)C(O)=O
XUJNEKJLAYXESH-UHFFFAOYSA-N
0.000
description
1
235000018417
cysteine
Nutrition
0.000
description
1
230000021953
cytokinesis
Effects
0.000
description
1
210000000805
cytoplasm
Anatomy
0.000
description
1
231100000135
cytotoxicity
Toxicity
0.000
description
1
230000003013
cytotoxicity
Effects
0.000
description
1
KXGVEGMKQFWNSR-UHFFFAOYSA-N
deoxycholic acid
Natural products
C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2
KXGVEGMKQFWNSR-UHFFFAOYSA-N
0.000
description
1
239000005547
deoxyribonucleotide
Substances
0.000
description
1
125000002637
deoxyribonucleotide group
Chemical group
0.000
description
1
238000009795
derivation
Methods
0.000
description
1
206010012601
diabetes mellitus
Diseases
0.000
description
1
238000003745
diagnosis
Methods
0.000
description
1
ANCLJVISBRWUTR-UHFFFAOYSA-N
diaminophosphinic acid
Chemical compound
NP(N)(O)=O
ANCLJVISBRWUTR-UHFFFAOYSA-N
0.000
description
1
230000004069
differentiation
Effects
0.000
description
1
210000001840
diploid cell
Anatomy
0.000
description
1
238000010494
dissociation reaction
Methods
0.000
description
1
230000005593
dissociations
Effects
0.000
description
1
NAGJZTKCGNOGPW-UHFFFAOYSA-N
dithiophosphoric acid
Chemical class
OP(O)(S)=S
NAGJZTKCGNOGPW-UHFFFAOYSA-N
0.000
description
1
GTZOYNFRVVHLDZ-UHFFFAOYSA-N
dodecane-1,1-diol
Chemical group
CCCCCCCCCCCC(O)O
GTZOYNFRVVHLDZ-UHFFFAOYSA-N
0.000
description
1
229960003722
doxycycline
Drugs
0.000
description
1
239000000975
dye
Chemical group
0.000
description
1
101150097231
eg gene
Proteins
0.000
description
1
235000013601
eggs
Nutrition
0.000
description
1
230000013020
embryo development
Effects
0.000
description
1
210000002257
embryonic structure
Anatomy
0.000
description
1
230000007071
enzymatic hydrolysis
Effects
0.000
description
1
238000006047
enzymatic hydrolysis reaction
Methods
0.000
description
1
CHNUOJQWGUIOLD-NFZZJPOKSA-N
epalrestat
Chemical compound
C=1C=CC=CC=1\C=C(/C)\C=C1/SC(=S)N(CC(O)=O)C1=O
CHNUOJQWGUIOLD-NFZZJPOKSA-N
0.000
description
1
230000029142
excretion
Effects
0.000
description
1
102000013165
exonuclease
Human genes
0.000
description
1
210000001723
extracellular space
Anatomy
0.000
description
1
GNBHRKFJIUUOQI-UHFFFAOYSA-N
fluorescein
Chemical group
O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21
GNBHRKFJIUUOQI-UHFFFAOYSA-N
0.000
description
1
239000007850
fluorescent dye
Substances
0.000
description
1
238000001215
fluorescent labelling
Methods
0.000
description
1
125000001153
fluoro group
Chemical group
F*
0.000
description
1
239000011724
folic acid
Chemical group
0.000
description
1
229960000304
folic acid
Drugs
0.000
description
1
235000019152
folic acid
Nutrition
0.000
description
1
238000010230
functional analysis
Methods
0.000
description
1
125000000524
functional group
Chemical group
0.000
description
1
238000003198
gene knock in
Methods
0.000
description
1
238000003197
gene knockdown
Methods
0.000
description
1
238000003209
gene knockout
Methods
0.000
description
1
238000012226
gene silencing method
Methods
0.000
description
1
235000003869
genetically modified organism
Nutrition
0.000
description
1
238000010362
genome editing
Methods
0.000
description
1
PEDCQBHIVMGVHV-UHFFFAOYSA-N
glycerol
Substances
OCC(O)CO
PEDCQBHIVMGVHV-UHFFFAOYSA-N
0.000
description
1
125000003827
glycol group
Chemical group
0.000
description
1
210000003783
haploid cell
Anatomy
0.000
description
1
230000035876
healing
Effects
0.000
description
1
230000036541
health
Effects
0.000
description
1
125000000592
heterocycloalkyl group
Chemical group
0.000
description
1
229920001519
homopolymer
Polymers
0.000
description
1
238000006460
hydrolysis reaction
Methods
0.000
description
1
230000008088
immune pathway
Effects
0.000
description
1
230000000415
inactivating effect
Effects
0.000
description
1
229910052738
indium
Inorganic materials
0.000
description
1
208000014674
injury
Diseases
0.000
description
1
150000002484
inorganic compounds
Chemical class
0.000
description
1
229910010272
inorganic material
Inorganic materials
0.000
description
1
230000002452
interceptive effect
Effects
0.000
description
1
210000003093
intracellular space
Anatomy
0.000
description
1
210000004153
islets of langerhan
Anatomy
0.000
description
1
AGPKZVBTJJNPAG-UHFFFAOYSA-N
isoleucine
Natural products
CCC(C)C(N)C(O)=O
AGPKZVBTJJNPAG-UHFFFAOYSA-N
0.000
description
1
239000008101
lactose
Substances
0.000
description
1
238000011031
large-scale manufacturing process
Methods
0.000
description
1
229940115932
legionella pneumophila
Drugs
0.000
description
1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N
leptin
Chemical compound
O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O
NRYBAZVQPHGZNS-ZSOCWYAHSA-N
0.000
description
1
229940039781
leptin
Drugs
0.000
description
1
101150111214
lin-28 gene
Proteins
0.000
description
1
230000004807
localization
Effects
0.000
description
1
230000033001
locomotion
Effects
0.000
description
1
210000004072
lung
Anatomy
0.000
description
1
241001515942
marmosets
Species
0.000
description
1
239000011159
matrix material
Substances
0.000
description
1
238000002844
melting
Methods
0.000
description
1
230000008018
melting
Effects
0.000
description
1
230000004060
metabolic process
Effects
0.000
description
1
229930182817
methionine
Natural products
0.000
description
1
125000000956
methoxy group
Chemical group
[H]C([H])([H])O*
0.000
description
1
125000002496
methyl group
Chemical group
[H]C([H])([H])*
0.000
description
1
108091070501
miRNA
Proteins
0.000
description
1
239000000693
micelle
Substances
0.000
description
1
239000002679
microRNA
Substances
0.000
description
1
230000005012
migration
Effects
0.000
description
1
238000013508
migration
Methods
0.000
description
1
230000025608
mitochondrion localization
Effects
0.000
description
1
230000000394
mitotic effect
Effects
0.000
description
1
108091005601
modified peptides
Proteins
0.000
description
1
108010065781
myosin light chain 2
Proteins
0.000
description
1
210000005155
neural progenitor cell
Anatomy
0.000
description
1
231100000252
nontoxic
Toxicity
0.000
description
1
230000003000
nontoxic effect
Effects
0.000
description
1
239000011824
nuclear material
Substances
0.000
description
1
238000006384
oligomerization reaction
Methods
0.000
description
1
230000005868
ontogenesis
Effects
0.000
description
1
150000002894
organic compounds
Chemical class
0.000
description
1
125000001181
organosilyl group
Chemical group
[SiH3]*
0.000
description
1
229910052760
oxygen
Inorganic materials
0.000
description
1
125000004430
oxygen atom
Chemical group
O*
0.000
description
1
125000000913
palmityl group
Chemical group
[H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
0.000
description
1
244000052769
pathogen
Species
0.000
description
1
230000037361
pathway
Effects
0.000
description
1
230000000144
pharmacologic effect
Effects
0.000
description
1
229950000688
phenothiazine
Drugs
0.000
description
1
150000002991
phenoxazines
Chemical class
0.000
description
1
COLNVLDHVKWLRT-UHFFFAOYSA-N
phenylalanine
Natural products
OC(=O)C(N)CC1=CC=CC=C1
COLNVLDHVKWLRT-UHFFFAOYSA-N
0.000
description
1
239000010452
phosphate
Substances
0.000
description
1
150000003008
phosphonic acid esters
Chemical class
0.000
description
1
150000008299
phosphorodiamidates
Chemical class
0.000
description
1
238000013081
phylogenetic analysis
Methods
0.000
description
1
230000004962
physiological condition
Effects
0.000
description
1
230000001766
physiological effect
Effects
0.000
description
1
229920002647
polyamide
Polymers
0.000
description
1
229920000728
polyester
Polymers
0.000
description
1
229920000570
polyether
Polymers
0.000
description
1
229920000656
polylysine
Polymers
0.000
description
1
239000011591
potassium
Substances
0.000
description
1
229910052700
potassium
Inorganic materials
0.000
description
1
125000002924
primary amino group
Chemical group
[H]N([H])*
0.000
description
1
230000001902
propagating effect
Effects
0.000
description
1
230000000069
prophylactic effect
Effects
0.000
description
1
102000021127
protein binding proteins
Human genes
0.000
description
1
108091011138
protein binding proteins
Proteins
0.000
description
1
108060006633
protein kinase
Proteins
0.000
description
1
238000001814
protein method
Methods
0.000
description
1
230000017854
proteolysis
Effects
0.000
description
1
IGFXRKMLLMBKSA-UHFFFAOYSA-N
purine
Chemical group
N1=C[N]C2=NC=NC2=C1
IGFXRKMLLMBKSA-UHFFFAOYSA-N
0.000
description
1
UBQKCCHYAOITMY-UHFFFAOYSA-N
pyridin-2-ol
Chemical compound
OC1=CC=CC=N1
UBQKCCHYAOITMY-UHFFFAOYSA-N
0.000
description
1
RXTQGIIIYVEHBN-UHFFFAOYSA-N
pyrimido[4,5-b]indol-2-one
Chemical compound
C1=CC=CC2=NC3=NC(=O)N=CC3=C21
RXTQGIIIYVEHBN-UHFFFAOYSA-N
0.000
description
1
SRBUGYKMBLUTIS-UHFFFAOYSA-N
pyrrolo[2,3-d]pyrimidin-2-one
Chemical compound
O=C1N=CC2=CC=NC2=N1
SRBUGYKMBLUTIS-UHFFFAOYSA-N
0.000
description
1
238000011084
recovery
Methods
0.000
description
1
108010054624
red fluorescent protein
Proteins
0.000
description
1
125000006853
reporter group
Chemical group
0.000
description
1
PYWVYCXTNDRMGF-UHFFFAOYSA-N
rhodamine B
Chemical group
[Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O
PYWVYCXTNDRMGF-UHFFFAOYSA-N
0.000
description
1
239000002336
ribonucleotide
Substances
0.000
description
1
125000002652
ribonucleotide group
Chemical group
0.000
description
1
125000000548
ribosyl group
Chemical group
C1([C@H](O)[C@H](O)[C@H](O1)CO)*
0.000
description
1
230000035945
sensitivity
Effects
0.000
description
1
238000002864
sequence alignment
Methods
0.000
description
1
238000012163
sequencing technique
Methods
0.000
description
1
230000001568
sexual effect
Effects
0.000
description
1
230000007044
single strand scission
Effects
0.000
description
1
239000011734
sodium
Substances
0.000
description
1
229910052708
sodium
Inorganic materials
0.000
description
1
210000002325
somatostatin-secreting cell
Anatomy
0.000
description
1
125000006850
spacer group
Chemical group
0.000
description
1
108010068698
spleen exonuclease
Proteins
0.000
description
1
230000002269
spontaneous effect
Effects
0.000
description
1
SIARJEKBADXQJG-LFZQUHGESA-N
stearoyl-CoA
Chemical compound
O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1
SIARJEKBADXQJG-LFZQUHGESA-N
0.000
description
1
235000021092
sugar substitutes
Nutrition
0.000
description
1
IIACRCGMVDHOTQ-UHFFFAOYSA-N
sulfamic acid
Chemical group
NS(O)(=O)=O
IIACRCGMVDHOTQ-UHFFFAOYSA-N
0.000
description
1
150000003456
sulfonamides
Chemical group
0.000
description
1
BDHFUVZGWQCTTF-UHFFFAOYSA-M
sulfonate
Chemical compound
[O-]S(=O)=O
BDHFUVZGWQCTTF-UHFFFAOYSA-M
0.000
description
1
150000003457
sulfones
Chemical group
0.000
description
1
150000003462
sulfoxides
Chemical class
0.000
description
1
239000011593
sulfur
Substances
0.000
description
1
239000003765
sweetening agent
Substances
0.000
description
1
230000009897
systematic effect
Effects
0.000
description
1
238000012360
testing method
Methods
0.000
description
1
229940124597
therapeutic agent
Drugs
0.000
description
1
150000003568
thioethers
Chemical class
0.000
description
1
RYYWUUFWQRZTIU-UHFFFAOYSA-K
thiophosphate
Chemical compound
[O-]P([O-])([O-])=S
RYYWUUFWQRZTIU-UHFFFAOYSA-K
0.000
description
1
ZEMGGZBWXRYJHK-UHFFFAOYSA-N
thiouracil
Chemical compound
O=C1C=CNC(=S)N1
ZEMGGZBWXRYJHK-UHFFFAOYSA-N
0.000
description
1
229940104230
thymidine
Drugs
0.000
description
1
230000001988
toxicity
Effects
0.000
description
1
231100000419
toxicity
Toxicity
0.000
description
1
230000005030
transcription termination
Effects
0.000
description
1
238000012546
transfer
Methods
0.000
description
1
230000001131
transforming effect
Effects
0.000
description
1
230000001052
transient effect
Effects
0.000
description
1
ZMANZCXQSJIPKH-UHFFFAOYSA-O
triethylammonium ion
Chemical compound
CC[NH+](CC)CC
ZMANZCXQSJIPKH-UHFFFAOYSA-O
0.000
description
1
OUYCCCASQSFEME-UHFFFAOYSA-N
tyrosine
Natural products
OC(=O)C(N)CC1=CC=C(O)C=C1
OUYCCCASQSFEME-UHFFFAOYSA-N
0.000
description
1
125000002948
undecyl group
Chemical group
[H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
0.000
description
1
238000011144
upstream manufacturing
Methods
0.000
description
1
210000004509
vascular smooth muscle cell
Anatomy
0.000
description
1
230000009385
viral infection
Effects
0.000
description
1
229940075420
xanthine
Drugs
0.000
description
1
210000005253
yeast cell
Anatomy
0.000
description
1
229910052727
yttrium
Inorganic materials
0.000
description
1
Classifications
A —HUMAN NECESSITIES
A01 —AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
A01H —NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
A01H6/00 —Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
A01H6/46 —Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
A01H6/4684 —Zea mays [maize]
A —HUMAN NECESSITIES
A01 —AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
A01K —ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
A01K67/00 —Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
A01K67/027 —New or modified breeds of vertebrates
A —HUMAN NECESSITIES
A61 —MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K —PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00 —Medicinal preparations containing peptides
A61K38/16 —Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K38/43 —Enzymes; Proenzymes; Derivatives thereof
A61K38/46 —Hydrolases (3)
A61K38/465 —Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
A —HUMAN NECESSITIES
A61 —MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P —SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00 —Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A —HUMAN NECESSITIES
A61 —MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P —SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00 —Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04 —Antibacterial agents
A —HUMAN NECESSITIES
A61 —MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P —SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00 —Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12 —Antivirals
A —HUMAN NECESSITIES
A61 —MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P —SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00 —Antineoplastic agents
A —HUMAN NECESSITIES
A61 —MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P —SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00 —Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
C —CHEMISTRY; METALLURGY
C12 —BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N —MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N15/00 —Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C12N15/09 —Recombinant DNA-technology
C12N15/10 —Processes for the isolation, preparation or purification of DNA or RNA